Products Description
Optimize Keywords: Veterinary Carbetocin
CAS Number: 37025-55-1
Standard: In-house standard
Veterinary carbetocin is a synthetic long-acting Oxytocin 8 peptide analog with agonist properties. Its clinical and pharmacological properties are similar to those of naturally produced Oxytocin. Like Oxytocin, Carbetocin binds to the hormone-producing receptors of uterine smooth muscle, causing rhythmic contraction of the uterus.
Introduce
Veterinary carbetocin , a synthetic analog of oxytocin, has been extensively studied and proven to be safe and effective in reducing postpartum hemorrhage. This characteristic makes it a highly recommended intervention in obstetric practice.
Numerous clinical trials have demonstrated the efficacy of veterinary carbetocin in preventing and treating postpartum hemorrhage. These studies have consistently shown that veterinary carbetocin significantly reduces the incidence of excessive bleeding compared to placebo or other uterotonic agents. By promoting uterine contractions, carbetocin helps to compress blood vessels in the uterus, thereby reducing the risk of postpartum hemorrhage. Its effectiveness in preventing excessive bleeding has made carbetocin an integral part of postpartum management protocols worldwide.
Moreover, veterinary carbetocin has been found to reduce the need for additional interventions in cases of postpartum hemorrhage. These interventions may include blood transfusions or surgical procedures, which carry their own risks and complications. By effectively controlling bleeding, carbetocin minimizes the reliance on these interventions, resulting in improved patient outcomes and reduced healthcare costs. The ability of carbetocin to provide effective hemostasis is particularly valuable in resource-limited settings where access to blood products or surgical facilities may be limited.
Safety is another critical aspect of carbetocin's characteristic as a uterotonic agent. Extensive research and clinical experience have shown that carbetocin is generally well-tolerated by most patients. Common side effects, such as nausea, vomiting, headache, and transient hypotension, are usually mild and self-limiting. However, as with any medication, carbetocin should be administered under medical supervision to ensure appropriate monitoring and prompt management of any potential adverse effects.
In summary, carbetocin's efficacy in reducing postpartum hemorrhage, its ability to minimize the need for additional interventions, and its favorable safety profile make it a valuable therapeutic option. Its use in clinical practice has been supported by robust evidence and international guidelines. Carbetocin's effectiveness in preventing excessive bleeding not only improves maternal outcomes but also has important implications for healthcare systems, reducing the burden on resources and improving cost-effectiveness.
Hot Tags: veterinary carbetocin, China veterinary carbetocin manufacturers, suppliers, factory, 9002-70-4, 34973-08-5, Triptorelin, Alarelin, PMSG, Veterinary Protein and Peptides
